Skip to main content
AmigoFish

JAMA Medical News

JAMA NetworkAudio

Format:
Podcast
New episodes:
Weekly
Typical length:
about 6 minutes
Latest episode:
Not rated yet

About this show

Discussions of timely topics in clinical medicine, biomedical research, public health, health policy, and more, featured in the Medical News section of JAMA, the Journal of the American Medical Association.

Covers: medicine, public health, clinical medicine, medical research, hypertension, infectious disease, cardiology, pharmacology, pediatrics, women's health

Show details and episodes come from the publisher's public feed at rss.libsyn.com. Last updated . Names, artwork and text belong to their publishers.

Recently on this show

Summary of recent episodes, drawn from the publisher's feed.

JAMA Medical News is a podcast from the JAMA Network covering timely topics in medicine, research, public health and health policy. Recent episodes cover salt substitutes, waist circumference, Pennsylvania's measles outbreak and testosterone use among women.

Report a problem with this summary

Cosmos

Similar in subject

See the full Cosmos

Similar shows

See all Health shows

Explore more

Episodes

  • Highlights From the 2026 Alzheimer's Association International Conference

    · 30 min

    Hear the latest on blood-based biomarkers, lifestyle interventions, and more from AAIC 2026 with Gil Rabinovici, MD. Related Content: - Soccer Players' Brains, P-Tau217 Blood Tests, Lifestyle and Dementia Risk, and More From AAIC 2026

    Not rated yet
  • Striking the Balance for Prescribing Opioids

    · 5 min

    JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance?" Related Content: - A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance?

    Not rated yet
  • The Menopause Treatment Boom

    · 5 min

    JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace." Related Content: - Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace

    Not rated yet
  • The First CKM Syndrome Guidelines Are Here

    · 5 min

    JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the First CKM Syndrome Guidelines." Related Content: - What to Know About the First CKM Syndrome Guidelines

    Not rated yet
  • The Testosterone Therapy Debate

    · 5 min

    JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?" Related Content: - Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?

    Not rated yet
  • Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected

    · 5 min

    JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds." Related Content: - First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds

    Not rated yet
  • PMOS is the New PCOS

    · 5 min

    JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "PCOS is Now PMOS—Will a New Name Translate to Improved Clinical Care?" Related Content: - PCOS Is Now PMOS—Will a New Name Translate to Improved Clinical Care?

    Not rated yet
  • New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions

    · 22 min

    Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more. Related Content: - A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026

    Not rated yet
  • Why Exercise Still Matters in the GLP-1 Drug Era

    · 4 min

    JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content: - In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA

    Not rated yet
  • The Search for a Fentanyl Vaccine

    · 5 min

    JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine." Related Content: - Inside the Push for a Fentanyl Vaccine

    Not rated yet
  • New Insights on HFpEF in Patients With Severe Obesity

    · 4 min

    JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity." Related Content: - HFpEF May Be a Different Disease in Patients With Severe Obesity

    Not rated yet
  • Ebola Outbreak Update

    · 6 min

    JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know." Related Content: - A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know

    Not rated yet
  • Is There a Doctor on the Ship?

    · 17 min

    Joining from quarantine, Stephen Kornfeld, MD, discusses his experience stepping in as the ship's physician when hantavirus transformed his vacation cruise into a global public health concern. Related Content: - Hantavirus Outbreak: First Test of US Public Health Response After WHO Withdrawal - When Hantavirus Sickened the Ship's Physician, Stephen Kornfeld, MD, Stepped Up

    Not rated yet
  • Bangladesh's New Measles Crisis

    · 4 min

    JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World." Related Content: - More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World

    Not rated yet
  • New Obesity Definition Stirs Debate

    · 6 min

    JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Experts Debate How Obesity Should Be Defined and Diagnosed." Related Content: - Experts Debate How Obesity Should Be Defined and Diagnosed

    Not rated yet
  • Multi-Cancer Blood Tests Have Arrived

    · 6 min

    JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives?" Related Content: - These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives?

    Not rated yet
  • Why GLP-1 Drugs Affect Patients Differently

    · 5 min

    JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics." Related Content: - Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics

    Not rated yet
  • Treating Methamphetamine Use Disorder With an Antidepressant

    · 3 min

    JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?" Related Content: - Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?

    Not rated yet
  • Cicada, the SARS-CoV-2 Variant With a Surprising Trajectory

    · 5 min

    JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring." Related Content: - What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring

    Not rated yet
  • Highlights From the American College of Cardiology's 2026 Scientific Sessions

    · 20 min

    Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting. Related Content: - PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC

    Not rated yet

More from JAMA Network

See all shows by JAMA Network